1-2 of 2
Michael Fradley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Adherence and Persistence to First-Line Ibrutinib or Acalabrutinib Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Atrial Fibrillation

Michael Fradley, Marie-Hélène Lafeuille, Bruno Emond, Samuel Crawford, Naijun Chen, Raisa Volodarsky, Jacqueline Nielsen, Bhavini Patel Srivastava
Journal: Blood
Blood (2022) 140 (Supplement 1): 10983–10984.
https://doi.org/10.1182/blood-2022-162797
Published: 2022
Journal Articles

Outcomes and Side Effect Profile of Ponatinib in Treatment of Chronic Myeloid Leukemia (CML): A Retrospective Single-Center Experience

Onyee Chan, MD, Chetasi Talati, MD, Leidy Isenalumhe, MD, Michael Fradley, MD, Samantha Shams, MD, Javier Pinilla Ibarz, MD, Kendra L. Sweet, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4259.
https://doi.org/10.1182/blood-2018-99-115660
Published: 2018